Heat Therapy for Esophageal Cancer Fayetteville NC

Radiofrequency ablation is an effective treatment for precancerous Barrett's esophagus, researchers have found. In people with Barrett's esophagus in Fayetteville, repeated acid reflux causes cells that line the esophagus to be replaced by cells similar to those found in the intestine, according to background information provided in a news release. A small number of people with Barrett's esophagus develop a deadly form of cancer called esophageal adenocarcinoma.

Cape Fear Animal Hospital
(910) 867-0103
3309 Bragg Blvd
Fayetteville, NC

Data Provided by:
A Healthy Back
(910) 390-0994
1248 Ft. Bragg Road
Fayetteville, NC

Data Provided by:
All Pets Hospital for Animals
(910) 323-5845
118 Cedar Creek Rd
Fayetteville, NC

Data Provided by:
Professional Eye Care Optometry
(910) 644-0941
3701 S Main
Hope Mills, NC

Data Provided by:
David D Stewart
(910) 484-1156
114 Broadfoot Ave
Fayetteville, NC
Specialty
Internal Medicine

Data Provided by:
Sears Eye Care - Cross Creek Mall
(910) 292-9979
4940 Morganton Rd
Fayetteville, NC

Data Provided by:
Seventy First Animal Hospital
(910) 487-5070
7103 Raeford Road
Fayetteville, NC

Data Provided by:
Cross Creek Animal Hospital
(910) 868-1164
2147 Skibo Rd.
Fayetteville, NC

Data Provided by:
Corey W Gilliland, DO
(910) 286-6917
Fayetteville, NC
Specialties
General Practice, Aerospace Medicine
Gender
Male
Education
Medical School: Univ Of Hlth Sci, Coll Of Osteo Med, Kansas City Mo 64124
Graduation Year: 1999

Data Provided by:
Shobha R Gali
(910) 486-6818
1248 Fort Bragg Rd
Fayetteville, NC
Specialty
Family Practice

Data Provided by:
Data Provided by:

Heat Therapy for Esophageal Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- Radiofrequency ablation is an effective treatment for precancerous Barrett's esophagus, researchers have found.

In people with Barrett's esophagus, repeated acid reflux causes cells that line the esophagus to be replaced by cells similar to those found in the intestine, according to background information provided in a news release. A small number of people with Barrett's esophagus develop a deadly form of cancer called esophageal adenocarcinoma.

The new study included 127 people randomly selected to receive either radiofrequency ablation (RFA) -- which uses heat to destroy abnormal cells -- or a "sham" version of the procedure, to assess the effect on dysplasia, a more advanced stage of Barrett's esophagus in which the abnormal cells acquire precancerous traits.

Among patients with low-grade dysplasia, 90.5 percent of those who received RFA were dysplasia-free 12 months after treatment, compared with 22.7 percent of those in the sham therapy group. Of those with high-grade dysplasia, 81 percent had complete eradication of abnormal cells, compared with 19 percent of those in the sham treatment group, the researchers found.

Overall, 77.4 percent of patients treated with RFA had complete eradication of abnormal cells, compared with 2.3 percent of the sham treatment group. The study also found that 3.6 percent of those in the RFA group and 16.3 percent of those in the sham group had progression towards disease, while 1.2 percent of RFA patients and 9.3 percent of sham patients developed esophageal adenocarcinoma.

"These results show there is a substantial difference between treatment with radiofrequency ablation and a placebo or 'sham' treatment. It's a strongly positive finding," principal investigator Dr. Nicholas Shaheen, director of the Center for Esophageal Diseases and Swallowing at the University of North Carolina at Chapel Hill, said in the news release.

The study, published in the May 28 issue of the New England Journal of Medicine, received funding from the company that makes the radiofrequency ablation unit used in the study.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about Barrett's esophagus.

SOURCE: University of North Carolina at Chapel Hill, news release, May 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com